B

BioPharma Dive

http://www.biopharmadive.com/feeds/news/ (RSS订阅地址)

Shareholder pressures Capricor; Lilly dives deeper into vaccines

<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webp"/></div></figure><p>Kaos Capital wants a &ldquo;governance reset&rdquo; to alter the Duchenne cell therapy maker&rsquo;s strategic course. Elsewhere, Bristol Myers furthered efforts to build an &ldquo;AI-powered&rdquo; discovery engine.</p>

8/21/2026
Read more

How cost and perception could reshape the GLP-1 market

<figure><div><img src="https://imgproxy.divecdn.com/17mmyyG9XnzYzW8xIH6-t7ISQUMLINaOm2eJGOQIfhM/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9nbHAtMS1yYWNlLmpwZw==.webp"/></div></figure><p>As Eli Lilly and Novo Nordisk race for share, surveys show affordability and prescribing preferences may help decide the winners.</p>

8/21/2026
Read more

Regeneron to challenge Ipsen as FDA clears bone disease drug

<figure><div><img src="https://imgproxy.divecdn.com/OFuJt8RCv7d5G0yYPlLx8Wpx6b0_2hQq__CLtXvugdU/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNzU0Mjc2NDAuanBn.webp"/></div></figure><p>Pasatru&rsquo;s approval sets up a market battle in a rare indication where the only available treatment has generated disappointing sales.</p>

8/21/2026
Read more

Cancer vaccine win restores Wall Street’s faith in Moderna

<figure><div><img src="https://imgproxy.divecdn.com/kTt-GkKwdvscVqt1TVdwU-EUFaQETvJaILkTKmje9Kk/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDE3Nzk1MTM4LmpwZw==.webp"/></div></figure><p>Moderna gained $45 billion in market value in a single day, a surge that brought the company&rsquo;s stock to levels not seen since 2024 &mdash; and saddled it with expectations that may be tough to meet.&nbsp;</p>

8/20/2026
Read more

Ultragenyx, after setbacks, nabs first gene therapy approval

<figure><div><img src="https://imgproxy.divecdn.com/ocnBveHz57dQBJpF-WborWHH7fBaDv-svbOIOsT1RCg/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjg5Nzg0NjM2LmpwZw==.webp"/></div></figure><p>The clearance of Genglycos for a rare glycogen storage disease gives Ultragenyx a sellable voucher and momentum ahead of an eagerly anticipated study readout.</p>

8/20/2026
Read more

Trump nominates policy aide Overton to lead FDA

<figure><div><img src="https://imgproxy.divecdn.com/0Ji_8vuSFNkANC4aPmbqLev61iJBHf6Kl3sGJt3LgMY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjI3NzEwNDk4X3pJUnRuUlcuanBn.webp"/></div></figure><p>Heidi Overton, a medical doctor and veteran of the America First think tank, currently serves as deputy director of the White House Domestic Policy Council.</p>

8/19/2026
Read more

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

<figure><div><img src="https://imgproxy.divecdn.com/l2fjcfreviwRnnixhxy6-Bvvb1WOizpHSalAEdf1bs8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy05ODA5ODcwMTQuanBn.webp"/></div></figure><p>At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna shares.</p>

8/19/2026
Read more

BioMarin acquires experimental drug for rare bone disorder in $275M deal

<figure><div><img src="https://imgproxy.divecdn.com/OFuJt8RCv7d5G0yYPlLx8Wpx6b0_2hQq__CLtXvugdU/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNzU0Mjc2NDAuanBn.webp"/></div></figure><p>The Alesta buyout helps restock BioMarin&#39;s pipeline with an asset it says could &ldquo;reach our largest addressable patient population,&rdquo; joining other muscle and skeletal disease treatments in development.</p>

8/18/2026
Read more

AstraZeneca scores in lung cancer; Sandoz inks a China deal

<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webp"/></div></figure><p>A combination of AstraZeneca&rsquo;s Tagrisso and Hutchmed&rsquo;s Orpathys extended survival for some lung cancer patients. Elsewhere, MapLight floated the idea of partnering on its autism drug.</p>

8/18/2026
Read more

Leo Pharma buys rare skin disease drug in $435M deal

<figure><div><img src="https://imgproxy.divecdn.com/nnTWCzHBd9_O2uNBVPF6xmxcO0M-nRFDpca5z-2Xchs/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDMwNzQzODA0LmpwZw==.webp"/></div></figure><p>Tanabe Pharma has already asked the FDA to approve the medicine for two conditions that cause severe reactions to sunlight.</p>

8/18/2026
Read more

Recommended Feeds

Chen's Blog

Chen's Blog，分享安全领域的所思、所想、所学。

空鸣深语

空鸣深语

游研社

无论你是游戏死忠，还是轻度的休闲玩家，在这里都能找到感兴趣的东西。

人民网 要闻快讯

要闻快讯

小众软件

分享免费、小巧、实用、有趣、绿色的软件